Dyslipidemia

Researchers estimate 43% of the roughly 3.1 million kidney stone episodes among US diabetics are related to type 2 diabetes mellitus (T2DM), while another 680,000 cases may result from poor glycemic control.

A researcher from the University of Central Florida Medical School addresses many concerns and misperceptions of fructose-containing sugars.

The risk calculator tool and recommendations included in the new American College of Cardiology (ACC)/American Heart Association (AHA) hyperlipidemia guidelines are open to significant debate.

Researchers reported finding large differences in the incidence rates of major cardiovascular disease across a broad range of immigrant groups to Canada.

Although oral antiplatelet therapy is broadly supported as preventive therapy for patients with established atherosclerotic vascular disease, researchers say emerging evidence for specific agents shows heterogeneous outcomes by symptomatic vascular bed, and patterns of use may vary by symptomatic territory.

Presentation at the 2013 Southern Hospital Medicine Conference reviewed the clinical application of several key risk indices, including the Revised Cardiac Risk Index and the Vascular Study Group of New England Risk Index.

Oxytocin has great potential to become a next-generation peptidyl drug target for obesity and diabetes.

A review of clinical evidence shows pharmacological agents that inhibit bone loss could slow the progression of atherosclerosis and cardiovascular disease (CVD).

A study published in the Journal of Urology found morbidly obese patients are more likely to develop uric acid kidney stones and less likely to develop calcium oxalate stones compared to normal weight controls.

Researchers have studied the effects of hormone therapy on the lipid profiles of postmenopausal women.

Though many patients indicate side effects as the reason they stop taking their prescribed statins, clinical trials have not documented high discontinuation rates due to adverse drug reactions.

A pair of researchers based in Texas has gained valuable insight into the correlation between individual cell type in the tissues of gout patients and comorbidity factors of the chronic inflammatory autoimmune disorder.

Hypertriglyceridemia combined with insulin resistance may lead to increased platelet activation in women with polycystic ovary syndrome (PCOS).

At ENDO 2013, an expert panel discussed the consensus statement on the evaluation and treatment of hypertriglyceridemia and the evidence supporting the recommendations.

Study results show improvements in body composition, intrahepatic lipids, and cardiovascular risk markers in obese men treated with growth hormone for six months compared with placebo.

Initial data show similar efficacy but different costs among injectable insulin treatments for patients who fail oral antidiabetic drugs.

A recent study suggests that skipping breakfast in overweight women may lead to insulin resistance.

Growing evidence suggests increased cardiovascular risk in patients with nonalcoholic fatty liver disease (NAFLD) - in particular nonalcoholic steatohepatitis (NASN) - but no data exists to support a specific management approach.

In diagnosing a patient with type 2 diabetes, an endocrinologist or primary care physician may struggle with developing healthy treatment targets when comorbid conditions like obesity and hypoglycemia are at play.

As an adjunct to diet and exercise, Amarin's lipid-regulating agent Vascepa (icosapent ethyl capsules) is indicated to reduce triglyceride levels in adult patients with severe hypertriglyceridemia, or very high triglyceride (TG) levels greater than or equal to 500 milligrams per deciliter (mg/dL).

From full-motion video demonstrations of orthopedic clinical tests to suites of disease activity score calculators, these apps for Google and Apple mobile devices provide rheumatologists with useful and easy-to-access information at crucial moments in diagnosis and treatment.

Study results presented at ACC.13 show that patients with unprotected left main coronary artery disease treated with double kissing crush stenting experienced fewer cases of restenosis and other major adverse events compared to patients who received culotte stenting.

Investigators in the expanded HORUS trial using CT scans of ancient mummies from multiple populations and geographic regions report finding evidence of probable or definite atherosclerosis in nearly one-third of samples.

Landmark study results presented at ACC.13 reveal patients with vascular disease treated with niacin therapy face increased risk of myopathy and other adverse events.

Recently released guidelines for the diagnosis and management of stable ischemic heart disease focus on evaluation and testing, risk factor modification, medical therapy and other therapeutic options, and follow-up.

Results from the RELAX-AHF show serelaxin reduces cardiovascular deaths and improves symptoms in patients with heart failure.

Study results presented at AHA 2012 indicate that revascularization using CABG in diabetic patients with multivessel disease provides better clinical outcomes than PCI and is more cost effective in the long run.

Results from a sub-study of the Trial to Assess Chelation Therapy (TACT) that focused on quality of life issues in patients who had previously suffered a heart attack and were treated with chelation therapy reveal no improvements in these patients' quality of life.